These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8756100

  • 1. An "all-oral" combination therapy in chronic lymphocytic leukemia including the oral idarubicin.
    Molica S, Levato D, Di Renzo N, La Sala A, Carotenuto M.
    Am J Hematol; 1996 Jul; 52(3):235-6. PubMed ID: 8756100
    [No Abstract] [Full Text] [Related]

  • 2. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T, Blonski JZ, Kasznicki M, Góra-Tybor J, Dmoszyñska A, Skotñicki A.
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [Abstract] [Full Text] [Related]

  • 3. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, Kusec R, Morabito F, Iacopino P, Lutz D.
    Cancer; 1997 Jun 01; 79(11):2107-14. PubMed ID: 9179056
    [Abstract] [Full Text] [Related]

  • 4. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V, Molica S, Capalbo S, Pogliani E, Battista C, Broccia G, Montillo M, Cuneo A, Leoni P, Specchia G, Castoldi G.
    Haematologica; 2001 Nov 01; 86(11):1165-71. PubMed ID: 11694402
    [Abstract] [Full Text] [Related]

  • 5. [Chronic lymphatic leukemia and Hodgkin's disease].
    Calvo Villas J, Ramírez Sánchez M, Sicilia Guillén F.
    Sangre (Barc); 1999 Oct 01; 44(5):393-4. PubMed ID: 10618924
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
    Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dmoszyńska A, Wojtaszko M, Skotnicki AB, Nowak W, Hellmann A, Lewandowski K, Zdziarska B, Konopka L, Ceglarek B, Dwilewicz-Trojaczek J, Boguradzki P, Kuliczkowski K, Sułek K, Warzocha K.
    Med Sci Monit; 2005 Oct 01; 11(10):PI71-9. PubMed ID: 16192912
    [Abstract] [Full Text] [Related]

  • 7. Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
    Zeidman A, Yarmolovsky A, Djaldetti M, Mittelman M.
    Haematologia (Budap); 1995 Oct 01; 26(3):173-5. PubMed ID: 7797147
    [Abstract] [Full Text] [Related]

  • 8. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J, Balaguer H, Cladera A.
    Sangre (Barc); 1997 Jun 01; 42(3):254-6. PubMed ID: 9381277
    [No Abstract] [Full Text] [Related]

  • 9. [Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study].
    Pérez del Río MJ, Fresno MF, Ramírez A, Veiga M, González M, Herrero A.
    Sangre (Barc); 1996 Dec 01; 41(6):469-71. PubMed ID: 9148425
    [Abstract] [Full Text] [Related]

  • 10. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O, Isikdogan A, Bolaman Z, Muftuoglu E.
    Saudi Med J; 2004 Dec 01; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract] [Full Text] [Related]

  • 11. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr 01; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 12. Combined use of alpha 2B-interferon, chlorambucil, and prednisone in the treatment of previously treated B-chronic lymphocytic leukemia patients.
    Molica S.
    Am J Hematol; 1993 Mar 01; 42(3):334-5. PubMed ID: 8438908
    [No Abstract] [Full Text] [Related]

  • 13. Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemia.
    Molica S.
    Eur J Haematol; 1992 Feb 01; 48(2):117-8. PubMed ID: 1547874
    [No Abstract] [Full Text] [Related]

  • 14. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
    Del Poeta G, Ilaria Del Principe M, Buccisano F, Maurillo L, Niscola P, Venditti A, Amadori S.
    Expert Rev Anticancer Ther; 2006 Dec 01; 6(12):1787-800. PubMed ID: 17181492
    [Abstract] [Full Text] [Related]

  • 15. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lv JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 01; 28(9):706-8. PubMed ID: 17274381
    [Abstract] [Full Text] [Related]

  • 16. Membranous glomerulonephritis in chronic lymphocytic leukemia.
    Ziakas PD, Giannouli S, Psimenou E, Nakopoulou L, Voulgarelis M.
    Am J Hematol; 2004 Jul 01; 76(3):271-4. PubMed ID: 15224365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
    Lindhagen E, Nissle S, Leoni L, Elliott G, Chao Q, Larsson R, Aleskog A.
    Cancer Chemother Pharmacol; 2007 Sep 01; 60(4):545-53. PubMed ID: 17186240
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR, Zinzani P, Zaja F, Gentile M, Vegna ML, Stefoni V, Marin L, Fanin R, Baccarani M, Tura S, Mandelli F.
    Haematologica; 2003 Dec 01; 88(12):1348-57. PubMed ID: 14687987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.